BullFrog AI says Australian patent issued for prodrugs of mebendazole
Share- Nishadil
- January 16, 2024
- 0 Comments
- 0.22 minutes read
- 21 Views
BullFrog AI ( NASDAQ: BFRG ) announced that the Australian Patent Office has issued patent protecting its novel prodrugs derived from mebendazole and their use in treating cancers and other diseases. This follows the July 2023 announcement of the issuance of U.S. Patent No. 11,712,435 for this invention, with issuance of patents expected in additional territories in the future. Source: Press Release More on Bullfrog AI Holdings, Inc. Financial information for Bullfrog AI Holdings, Inc.
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on
